The paucity of evidence supporting screening for stages 1-3 CKD in asymptomatic patients with or without risk factors
- PMID: 25237074
- PMCID: PMC4220758
- DOI: 10.2215/CJN.02940314
The paucity of evidence supporting screening for stages 1-3 CKD in asymptomatic patients with or without risk factors
Abstract
The American College of Physicians recently published a guideline on screening for CKD that recommends against screening for CKD in asymptomatic adults without risk factors. The generally accepted criteria for population-based screening for disease state that screening should improve important clinical outcomes while limiting harms for those individuals screened. However, CKD screening does not meet these criteria. There is currently no evidence evaluating or demonstrating benefits for providing early treatment for patients identified via screening who do not have risk factors. On the other hand, harms are associated with the screening and include false-positive results, unnecessary testing and treatment, and disease labeling.
Keywords: CKD; clinical nephrology; microalbuminuria.
Copyright © 2014 by the American Society of Nephrology.
References
-
- Qaseem A, Hopkins RH, Jr, Sweet DE, Starkey M, Shekelle P; Clinical Guidelines Committee of the American College of Physicians: Screening, monitoring, and treatment of stage 1 to 3 chronic kidney disease: A clinical practice guideline from the American College of Physicians. Ann Intern Med 159: 835–847, 2013 - PubMed
-
- Qaseem A, Forland F, Macbeth F, Ollenschläger G, Phillips S, van der Wees P; Board of Trustees of the Guidelines International Network: Guidelines International Network: Toward international standards for clinical practice guidelines. Ann Intern Med 156: 525–531, 2012 - PubMed
-
- Wilson JMG, Jungner G: Principles and Practice of Screening for Disease, Geneva, Switzerland, World Health Organization, 1968
-
- Fink HA, Ishani A, Taylor BC, Greer NL, MacDonald R, Rossini D, Sadiq S, Lankireddy S, Kane RL, Wilt TJ; Minnesota Evidence-Based Practice Center: Chronic Kidney Disease Stages 1–3: Screening, Monitoring, and Treatment. Comparative Effectiveness Reviews, No. 37, AHRQ Publication No. 11(12)-EHC075-EF, Rockville, MD, Agency for Healthcare Research and Quality, 2012 - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
